It is believed that the discovery of antimicrobials almost 90 years ago changed the course of modern medicine, giving doctors the ability to treat previously fatal infections. Since then, millions of lives have been saved.
Pfizer has recommitted to sustained breakthroughs that impact lives positively around the world, just as it recognised influence of patients on every facet of its work.
National Health Insurance Authority (NHIA) has signed a Memorandum of Understanding (MOU) on cost sharing with a leading biotech company, Pfizer, on dispensing of critical antibiotics medicine Meronem(c) (MEROPENEM) for treatment of infections.
One of them is Pfizer. Pfizer reported a 92% operational growth in revenue to $81.3 billion for the full year 2021, compared with $41.7bn for the full year 2020 mainly from Comirnaty which is a COVID-19 vaccine...
Pfizer commits to provide both current, future vaccines to 1.2bn people in 45 lower income countries
Pfizer announced its new commitment to providing vaccines, both current and future vaccines, on a non-profit basis to 1.2 billion people living in the 45 lower-income countries
Pfizer reported another quarter of huge revenues growth because of its Covid-19 vaccine on Tuesday, but lowered the company's full-year profit forecast due in part to shifts in foreign exchange.
•Non-profit company to produce generic insulin that will be sold for $30 per vial as discussions of price-caps for lifesaving drug is sparked after State of the Union address Pfizer and Moderna, manufacturers of the two most popular used vaccines in the United States and much of the rest of the world, are expecting to…
Pfizer in Africa and the Middle East region (AfME) announced on Tuesday, March 1, 2022 in a media roundtable, their plans for delivering breakthroughs
Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.
Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday. Pfizer's CEO Albert Bourla has previously said that the pharmaceutical giant could be ready to file for regulatory approval of…
23 Dec 2021
The United States on Wednesday authorized Pfizer's anti-Covid pill for high-risk people aged 12 and up, as a surge of cases driven by the highly infectious Omicron variant threatened holiday plans and Americans struggled to find tests.
14 Dec 2021
Pfizer said Tuesday that clinical trials confirmed its Covid pill, a new type of antiviral treatment that should withstand the mutations seen with Omicron, drastically reduced hospitalizations and deaths among at-risk people by almost 90 percent.